Highlights from the 2019 International Aspirin Foundation Scientific Conference, Rome, 28 June 2019: Benefits and risks of antithrombotic therapy for cardiovascular disease prevention

Jaqui Walker, Marco Cattaneo, Lina Badimon, Giancarlo Agnelli, Andrew T. Chan, Angel Lanas, Bianca Rocca, Peter Rothwell, Paola Patrignani, Ruth Langley, Gemma Vilahur, Francesco Cosentino

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

At the 2019 International Aspirin Foundation Scientific Conference ‘Benefits and Risks of Antithrombotic Therapy for Cardiovascular Disease Prevention', held in Rome, Italy, international experts sought to discuss and debate the optimal antithrombotic strategy for the secondary prevention of cardiovascular disease (CVD) and to seek agreement around dosing and target populations for aspirin use in primary disease prevention. Getting the best evidence to support real-life decisions in the clinic can be complex, and individualising management in order to balance both the risks and benefits of different disease prevention strategies appears to be the best approach. It is hoped that future decision-making tools and biomarkers will help direct treatments at those most likely to benefit.

Original languageEnglish
Article number998
Journalecancermedicalscience
Volume14
DOIs
StatePublished - 13 Jan 2020
Externally publishedYes

Keywords

  • Anticoagulant
  • Antiplatelet
  • Antithrombotic
  • Aspirin
  • Benefit
  • Cardiovascular disease (CVD)
  • Colorectal cancer (CRC)
  • Diabetes mellitus (DM)
  • Gastroprotectant agents
  • Optimizing aspirin dose
  • Precision medicine
  • Primary prevention
  • Risk
  • Secondary prevention
  • Targeting
  • Upper gastrointestinal (GI) bleeding

Fingerprint

Dive into the research topics of 'Highlights from the 2019 International Aspirin Foundation Scientific Conference, Rome, 28 June 2019: Benefits and risks of antithrombotic therapy for cardiovascular disease prevention'. Together they form a unique fingerprint.

Cite this